IHH supportive of efforts to rein in medical inflation


KUALA LUMPUR: IHH Healthcare Bhd said it is supportive of the government's efforts to rein in medical inflation. 

However, it believes that it is crucial to enact policies that holistically address the issue by considering the healthcare financing structure and its various stakeholders, and not focus strictly on drug price controls per se. 
 
IHH also said it remains fully aligned with Association of Private Hospitals Malaysia’s call and efforts to continue collaborative engagement with the authorities and broader stakeholders to ensure an effective solution to tackle medical inflation in Malaysia.

Its managing director and CEO Dr Tan See Leng also said after it’a AGM he was unable to reveal the profit margins of its hospital’s drug division or IHH’s pharmaceutical division because certain more complex procedures using the same drugs required more technical expertise to administer.

IHH is the owner and operator of the Pantai and Gleneagles private hospitals in Malaysia.

Tan, 54, will be leaving the group once his contract expires on Dec 31, 2019.

Meanwhile, Dr Kelvin Loh Chi-Keon, 45, who is currently the Columbia Asia Group CEO, will take over the helm of IHH starting next year.

(An earlier version of this story titled “IHH supportive of drug price control mechanism” is now updated / corrected to this version)


Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 1
Cxense type: free
User access status: 0
Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!

IHH Healthcare

   

Next In Business News

Hong Seng acquires 51% stake in Innov8tif for RM30.8mil
Proton commerce hit new record volume of loan disbursements in 2022
Ringgit ends lower versus greenback on external pressure
Bursa Malaysia targets 39 IPO listings in 2023 with RM10bil market capitalisation
Pavilion REIT 4Q net profit surges to RM216.4mil
Nova MSC collaborates with Theta on marketing and promotion of healthcare solutions
Cypark unaware of reason for UMA
Pasukhas wins RM21mil contract in Johor
LCT braces for challenging outlook
Boustead Plantations directors resign to pursue other interests

Others Also Read